Psychiatric Manifestations Associated With Behcet's Disease

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04585360

Acronym

PSYCHO-B7

Enrollment

Registered

2020-10-14

Start date

2020-06-23

Completion date

2020-12-18

Last updated

2026-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behçet's Disease, Psychiatric Disorders

Keywords

NeuroBehçet, Anxiety, Depression, Tiredness

Brief summary

The psychoBehçet'study is aimed at evaluating the psychological and neurocognitive symptoms in 25 consecutive patients followed for Behçet's disease. This is a monocentric, observational, non interventional study.

Detailed description

Patients will be evaluated during a day-care facility for Behçet's disease activity together with evaluation of anxiety and depression symptoms (SCL90-R and MINI assessments), fatigue (MFI) and quality of life (SF36).

Interventions

OTHERQuestionnaires evaluating anxiety and depression symptoms, tiredness, and quality of life

Realization of specific questionnaires evaluating: * psychiatric symptoms (self-assessment according to the SLC-90R questionnaire and hetero-assessment by the internist doctor of the center according to the M.I.N.I. questionnaire) * fatigue (Multidimensional Fatigue Inventory (MFI-20), French version, in self-assessment) * quality of life (SF36 self-assessment questionnaire)

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adult male or female * Regular follow-up in the internal medicine department of Bicetre hospital * Diagnosed with Behçet's disease

Exclusion criteria

* Refusal to participate in the study * Poor command of the French language * Patients under legal protection * Pregnant woman

Design outcomes

Primary

Measure	Time frame	Description
SCL90-R questionnaire	Inclusion visit	Anxiety/depression symptoms questionnaire

Secondary

Measure	Time frame	Description
MINI questionnaire	Inclusion visit	Anxiety/depression symptoms questionnaire
Multidimensional Fatigue Inventory (MFI-20) questionnaire	Inclusion visit	Tiredness assessment
SF36 questionnaire	Inclusion visit	Quality of life
BSAS/BDCAF evaluation	Inclusion visit	Behçet's disease activity

Countries

France

Contacts

PRINCIPAL_INVESTIGATORNOEL NN Nicolas, MD PhD

APHP, Hôpital Bicetre

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026